In addition, dBET6, a chemical degrader of BET proteins, can inhibit the proliferation and self-renewal ability of GBM cells by significantly reducing BET protein occupancy, RNA pol II activity, and active histone markers, and dBET6 is superior to first-generation BRD4 inhibitors such as JQ1160,161. Here, BRD4 is linked to glioblastoma.